High Volume Trading Activity (COST, SBAC, WSM, PDLI)

Los Angelas, CA -- (SBWIRE) -- 10/10/2012 -- Costco Wholesale (NasdaqNM:COST) is very active today and traded between $101.59 - 104.43 with total traded volume of 3941541 shares. At a current price of 102.60, COST is +2.9599 - +2.97% from the previous close of $99.6401. Moreover, At Current Market Price, COST is in the distance of +2.87% from its 50-day Moving Average price of $99.7417 and +10.75% from its 200-day Moving Average price of $92.6438. Costco Wholesale Corp.'s ($103.89, +$4.25, +4.27%) fiscal fourth-quarter earnings rose 27% as higher membership fees helped the wholesale-club operator improve margins. The company's earnings and revenue beat analyst expectations. The warehouse retailer earned $1.39 per share for its fourth quarter, eight cents above estimates, while revenue also beat the consensus. Same-store sales rose by 5 percent from a year earlier.

Should Investor Buy OR Sell This Stock ? CLICK HERE

SBA Communication (NasdaqNM:SBAC) is +0.30 - +0.46% from the previous close of $65.16. It traded between $65.08 - 65.85 with total traded volume of 1701401 shares. Keep a close eye on SBAC, as the stock has been showing unusual moves over the past weeks. At Current market price, SBAC has recovered +84.76% from its 52-week Low of 35.43 and has Pulled back +0.20% from its 52-week high of 65.33.SBA Communications (NASDAQ: SBAC) shares rose 0.60% to create a new 52-week high of $65.55. SBA Communications is expected to release its Q3 results after the closing bell on November 5, 2012.

Can SBAC Extend Rally? Free sign up here

William Blair upgraded shares of Williams Sonoma (NYSE: WSM) from a market perform rating to an outperform rating in a report issued on Wednesday.Williams-Sonoma, Inc.(NYSE:WSM) shares climbed 2.30% to $45.78 in the early hour after William Blair upgraded shares of Williams Sonoma from a market perform rating to an outperform rating in a report issued today. Separately, analysts at ISI Group downgraded shares of Williams Sonoma from a buy rating to a hold rating in a research note to investors on September 27.Additionally, the company announced that its Board of Directors has declared a quarterly cash dividend of $0.22 per common share. The dividend is payable on November 23, 2012 to stockholders of record as of the close of business on October 26, 2012.

How Should Investors Trade WSM Now? Find Out Here

PDL BioPharma, Inc. (PDLI) is a is a biotech company. PDLI is engaged in the management of antibody humanization patents and royalty assets, which consist of its Queen et al. Patents and licensing agreements with various biotechnology and pharmaceutical companies. PDLI BioPharma PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. Today, PDLI is focused on intellectual property asset management, investing in new revenue generating assets and maximizing the value of its patent portfolio and related assets. PDL BioPharma, In (NasdaqNM: PDLI) reported EPS in 1.293. For the Current Fiscal year, the company is expected to report EPS of 1.45. For the Next Quarter and Next Year, the company is expected to report EPS of 0.32 and 1.75 respectively. At Current Market Price, PDLI is in the distance of +7.63% from its 50-day Moving Average price of $7.5906 and +20.06% from its 200-day Moving Average price of $6.805.

Can PDLI Extend Rally? Free sign up here

DISCLAIMER:

Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..

Contact:
hotpennystocknews.com
info@hotpennystocknews.com